菜单

Complementary Medicines Australia

Complementary Medicines Australia (CMA) is the peak industry body for the complementary medicines industry, representing members across the supply chain, including manufacturers, importers, exporters, raw material suppliers, wholesalers, distributors and retailers. CMA promotes appropriate industry regulation and advancement to ensure consumers have access to complementary medicines of the highest quality.

CMA is the principal reference point for members, the government, the media and consumers to communicate about issues relating to the complementary medicines industry. CMA is proud to work closely with the TGA and other Australian government agencies, such as Austrade and DFAT, to ensure a strong and sustainable industry.  It is CMA’s aim to improve public health and wellbeing through education and information on the use of complementary medicines, to support and enhance a robust complementary healthcare products industry, and to support the ethical and responsible promotion of complementary medicines.

http://www.cmaustralia.org.au

Complementary medicines: vitamins and minerals, nutritional supplements, herbal and homeopathic medicines, aromatherapy products, natural cosmetics using herbals and botanicals and traditional medicines.

澳大利亚保健品协会

澳大利亚保健品协会（CMA）是保健品产业的高峰组织，代表会员横跨整个供应链，包括制造商、进口商、出口商、原材料供应商、批发商、经销商和零售商。CMA通过严格的产业监管确保消费者使用的保健品达到**标准。

CMA是协会成员、政府、媒体和消费者关于保健品行业相关问题的主要参考点和联系机构。CMA与TGA、澳大利亚贸易委员会、外交部和贸易部等澳大利亚政府机构紧密合作，以确保行业健康、可持续发展。CMA的宗旨是通过向公众传播和教导保健品知识来提高促进人们的健康与福祉；支持和巩固保健品产业的稳健发展；支持和促进保健品要负责任地推广并且符合论理性。

http://www.cmaustralia.org.au

补充医药产品：维生素和矿物质、营养补充剂、草本植物和顺势疗法**、芳香疗法产品和天然草本化妆品和**。

Australian Complementary Medicines Industry

The complementary medicines sector in Australia has evolved into a major world class industry that supports domestic manufacturing, jobs, research and exports. Consumers worldwide are increasingly turning to complementary medicines as part of a proactive approach to healthcare, becoming more confident in self-selection and willing to take preventive measures to support their health. The Australian industry has been a success story in recent years due to a growing international demand for our complementary medicine products, which are seen globally as safe, effective and of exceptional quality. 

In Australia, the regulation of complementary medicines falls within the remit of the Therapeutic Goods Administration (TGA), which has the responsibility of regulation of all therapeutic goods, including medicines and medical devices. Australia’s complementary medicines industry is proud to be backed by a regulatory regime that is regarded as one of the strongest in the world.

The Therapeutic Goods Act 1989 (the Act), and the associated legislation, sets out the key elements of Australia’s regulatory scheme for therapeutic goods. The Act provides for a national system of controls relating to the quality, safety, efficacy, performance and timely availability of therapeutic goods used in Australia or exported from Australia. These controls are risk-based, with a two-tiered system for the regulation of all medicines, including complementary medicines.

There are over 12 000 complementary medicines available on the Australian market. These are included in the Australian Register of Therapeutic Goods (ARTG), which is a requirement for a therapeutic good to be lawfully supplied in Australia (a few complementary medicines are exempt from the requirement to be included on the ARTG, such as certain preparations of homoeopathic medicines). The vast majority of complementary medicines are in the lower risk listed category and there are approximately 140 products in the higher risk registered category.

Australia’s complementary medicines industry is backed by a regulatory regime that is regarded as one of the strongest in the world. Products are manufactured to a pharmaceutical standard under Good Manufacturing Practice (GMP), and strict safety and quality regulations are enforced by the TGA. 

澳大利亚保健品行业

澳大利亚保健品行业已经发展成为支持国内制造业、就业、科研和出口的产业。世界各地消费者越来越多地将辅助医药产品作为积极主动的保健方式，他们更加自信地选择保健品来预防疾病并支持他们的健康。近年来，随着世界各地消费者对保健品需求的增加及对澳大利亚安全、有效、优质保健品的青睐，保健品行业已经成为澳大利亚产业的成功典范。

在澳大利亚，保健品行业非常自豪地接受澳大利亚**管理局（TGA）的监管。TGA被公认为世界上**严格的监管机构，对药品和医疗仪器等**性产品进行监管。

**品法案和相关法规为澳大利亚**品设定了监管准则。该法案为澳大利亚及其出口**品的质量、安全、功效、性能和及时可用性设立了一套国家管制系统。这些管制措施以风险为基础，是一套为包括保健品在内所有药品提供监管的双层系统。

澳大利亚市场有超过12000种辅助医药产品。为了符合澳大利亚**品合法供应的要求，这些产品会进行澳大利亚**品登记（ARTG）。（少数保健品不需要被ARTG要求进行登记，例如一些顺势疗法**的配制品。）大多数保健品归属于低风险类别，而有140种产品归属于高风险类别。

澳大利亚保健品行业由世界**严格的监管制度把关。按“生产质量管理规范”（GMP）的要求，保健品的生产需要达到制药标准，同时还要符合 “澳大利亚**管理局”（TGA）严格的质量安全标准。